One year in review 2016: spondyloarthritis.
Spondyloarthritis represents a heterogeneous group of articular inflammatory diseases that share common genetic, clinical and radiological features. Recently, novel insights into the epidemiology, pathogenesis and treatment of these diseases have been provided. Herewith, we present an overview ofthe most significant literature contributions published over the past year.
Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
Alice
A
Parma
Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Florence, Italy.
Laura
L
Cometi
Rheumatology Unit, University of Perugia, Italy.
Maria Comasia
MC
Leone
Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Florence, Italy.
Gemma
G
Lepri
Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy. sara.talarico76@gmail.com.
Rosaria
R
Talarico
Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Florence, Italy.
Serena
S
Guiducci
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use; D001688:Biological Products / Q000627:therapeutic use; D016207:Cytokines / Q000378:metabolism; D006801:Humans; D015994:Incidence; D015995:Prevalence; D025241:Spondylarthritis / Q000188:drug therapy* / Q000453:epidemiology* / Q000209:etiology
D000894:Anti-Inflammatory Agents, Non-Steroidal; D018501:Antirheumatic Agents; D001688:Biological Products; D016207:Cytokines